Skip to main content
Fig. 2 | EJNMMI Radiopharmacy and Chemistry

Fig. 2

From: Evaluation of the pharmacokinetics, dosimetry, and therapeutic efficacy for the α-particle-emitting transarterial radioembolization (αTARE) agent [225Ac]Ac-DOTA-TDA-Lipiodol® against hepatic tumors

Fig. 2

Biodistribution of [225Ac]Ac-DOTA-TDA-Lipiodol® in tumor bearing female and male mice in: A blood, C kidneys, E liver, G tumor, and I femur w/ marrow. Biodistribution of the decay daughters francium-221 (including astatine-217) and bismuth-213 (including polonium-213) in tumor bearing female mice in B blood, D kidneys, F liver, H tumor, and J femur w/ marrow

Back to article page